Future Perspective: Carbon Ion Radiotherapy for Head and Neck and Skull Base Malignancies

Abstract

Head and neck and base of skull malignancies are challenging for surgical and radiotherapy treatment due to the density of sensitive tissues. Carbon ion radiotherapy (CIRT) is a form of heavy particle therapy that uses accelerated carbon ions to treat malignancies that may be radioresistant or in challenging anatomic locations. CIRT has an increased biological effectiveness (ie, increased cell killing) at the end of the range of the carbon beam (ie, within the target tissue) but not in the entrance dose. This increased biological effectiveness can overcome the effects of radioresistant tumors, tissue hypoxia, and the need for radiotherapy fractionation.

Keywords: Adenoid cystic carcinoma; Carbon ion radiotherapy; Chondrosarcoma; Chordoma; Head and neck cancer; Particle therapy; Radiotherapy; Skull base malignancies.